Business Segment Information (Tables)

6 Months Ended

Jun. 28, 2014

Business Segments

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information
				Three Months Ended						Six Months Ended
			June 28,			June 29,			June 28,			June 29,
(In millions)				2014			2013			2014			2013
Revenues
	Life Sciences Solutions			$	1,103.1		$	181.0		$	1,938.6		$	353.6
	Analytical Instruments				793.4			761.0			1,563.3			1,501.1
	Specialty Diagnostics				855.1			793.6			1,668.8			1,599.2
	Laboratory Products and Services				1,699.4			1,595.0			3,289.9			3,151.3
	Eliminations				(129.1)			(90.5)			(235.2)			(173.6)
		Consolidated revenues			4,321.9			3,240.1			8,225.4			6,431.6
Segment Income
	Life Sciences Solutions (a)				299.1			43.5			543.7			84.5
	Analytical Instruments (a)				130.4			125.3			261.3			245.8
	Specialty Diagnostics (a)				236.4			216.3			457.4			439.2
	Laboratory Products and Services (a)				257.7			238.7			491.7			469.4
		Subtotal reportable segments (a)			923.6			623.8			1,754.1			1,238.9
	Cost of revenues charges				(156.1)			(13.1)			(324.6)			(26.3)
	Selling, general and administrative charges, net				(14.9)			(22.6)			(97.7)			(23.9)
	Restructuring and other (costs) income, net				(60.9)			(21.5)			521.3			(43.0)
	Amortization of acquisition-related intangible assets				(343.6)			(191.2)			(629.5)			(383.2)
		Consolidated operating income			348.1			375.4			1,223.6			762.5
	Other expense, net (b)				(111.6)			(95.4)			(212.7)			(139.6)
	Income from continuing operations before income taxes			$	236.5		$	280.0		$	1,010.9		$	622.9
Depreciation
	Life Sciences Solutions			$	36.3		$	4.1		$	60.3		$	8.2
	Analytical Instruments				9.2			9.8			19.6			20.0
	Specialty Diagnostics				19.2			18.1			38.0			36.6
	Laboratory Products and Services				26.5			26.0			53.0			52.2
		Consolidated depreciation		$	91.2		$	58.0		$	170.9		$	117.0
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information
				Three Months Ended						Six Months Ended
			June 28,			June 29,			June 28,			June 29,
(In millions)				2014			2013			2014			2013
Revenues
	Life Sciences Solutions			$	1,103.1		$	181.0		$	1,938.6		$	353.6
	Analytical Instruments				793.4			761.0			1,563.3			1,501.1
	Specialty Diagnostics				855.1			793.6			1,668.8			1,599.2
	Laboratory Products and Services				1,699.4			1,595.0			3,289.9			3,151.3
	Eliminations				(129.1)			(90.5)			(235.2)			(173.6)
		Consolidated revenues			4,321.9			3,240.1			8,225.4			6,431.6
Segment Income
	Life Sciences Solutions (a)				299.1			43.5			543.7			84.5
	Analytical Instruments (a)				130.4			125.3			261.3			245.8
	Specialty Diagnostics (a)				236.4			216.3			457.4			439.2
	Laboratory Products and Services (a)				257.7			238.7			491.7			469.4
		Subtotal reportable segments (a)			923.6			623.8			1,754.1			1,238.9
	Cost of revenues charges				(156.1)			(13.1)			(324.6)			(26.3)
	Selling, general and administrative charges, net				(14.9)			(22.6)			(97.7)			(23.9)
	Restructuring and other (costs) income, net				(60.9)			(21.5)			521.3			(43.0)
	Amortization of acquisition-related intangible assets				(343.6)			(191.2)			(629.5)			(383.2)
		Consolidated operating income			348.1			375.4			1,223.6			762.5
	Other expense, net (b)				(111.6)			(95.4)			(212.7)			(139.6)
	Income from continuing operations before income taxes			$	236.5		$	280.0		$	1,010.9		$	622.9
Depreciation
	Life Sciences Solutions			$	36.3		$	4.1		$	60.3		$	8.2
	Analytical Instruments				9.2			9.8			19.6			20.0
	Specialty Diagnostics				19.2			18.1			38.0			36.6
	Laboratory Products and Services				26.5			26.0			53.0			52.2
		Consolidated depreciation		$	91.2		$	58.0		$	170.9		$	117.0
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.